Wells Fargo
BLUE

Wells Fargo’s bluebird bio BLUE Stock Holding History

Wells Fargo’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,499
Closed -$31.7K – 7154
2025
Q1 		$31.7K Buy
6,499
+238
+4% +$1.43K ﹤0.01% 5547
2024
Q4 		$52.2K Buy
6,261
+1,173
+23% +$10.3K ﹤0.01% 5470
2024
Q3 		$52.9K Buy
5,088
+44
+0.9% +$731 ﹤0.01% 5326
2024
Q2 		$99.3K Buy
5,044
+606
+14% +$12.1K ﹤0.01% 4948
2024
Q1 		$114K Buy
4,438
+1,934
+77% +$49.6K ﹤0.01% 4816
2023
Q4 		$69.1K Sell
2,504
-11,618
-82% -$708K ﹤0.01% 5128
2023
Q3 		$859K Sell
14,122
-3,422
-20% -$240K ﹤0.01% 3428
2023
Q2 		$1.15M Buy
17,544
+1,869
+12% +$137K ﹤0.01% 3368
2023
Q1 		$997K Buy
15,675
+12,832
+451% +$1.47M ﹤0.01% 3381
2022
Q4 		$393K Sell
2,843
-2,076
-42% -$292K ﹤0.01% 3778
2022
Q3 		$623K Buy
4,919
+1,893
+63% +$214K ﹤0.01% 3561
2022
Q2 		$251K Buy
3,026
+1,354
+81% +$105K ﹤0.01% 4162
2022
Q1 		$162K Sell
1,672
-1,211
-42% -$160K ﹤0.01% 5096
2021
Q4 		$575K Sell
2,883
-6,156
-68% -$1.45M ﹤0.01% 4546
2021
Q3 		$2.24M Sell
9,039
-6,116
-40% -$1.75M ﹤0.01% 3573
2021
Q2 		$6.28M Sell
15,155
-3,305
-18% -$1.31M ﹤0.01% 2645
2021
Q1 		$7.21M Sell
18,460
-3,752
-17% -$1.85M ﹤0.01% 2491
2020
Q4 		$12.4M Buy
22,212
+1,902
+9% +$1.21M ﹤0.01% 1917
2020
Q3 		$14.2M Buy
20,310
+1,218
+6% +$950K ﹤0.01% 1650
2020
Q2 		$15.1M Buy
19,092
+1,657
+10% +$1.25M ﹤0.01% 1548
2020
Q1 		$10.4M Buy
17,435
+2,787
+19% +$2.72M ﹤0.01% 1642
2019
Q4 		$16.6M Buy
14,648
+3,594
+33% +$3.91M ﹤0.01% 1581
2019
Q3 		$13.1M Buy
11,054
+71
+0.6% +$108K ﹤0.01% 1744
2019
Q2 		$18.1M Buy
10,983
+919
+9% +$1.59M 0.01% 1531
2019
Q1 		$20.5M Buy
10,064
+2,843
+39% +$5.01M 0.01% 1422
2018
Q4 		$9.28M Buy
7,221
+1,808
+33% +$2.77M ﹤0.01% 1911
2018
Q3 		$10.2M Buy
5,413
+216
+4% +$446K ﹤0.01% 2055
2018
Q2 		$10.6M Sell
5,197
-1,241
-19% -$2.83M ﹤0.01% 2027
2018
Q1 		$14.2M Buy
6,438
+462
+8% +$1.18M ﹤0.01% 1699
2017
Q4 		$13.8M Sell
5,976
-13,653
-70% -$27.7M ﹤0.01% 1749
2017
Q3 		$34.9M Sell
19,629
-3,255
-14% -$4.55M 0.01% 1091
2017
Q2 		$31.1M Sell
22,884
-3,369
-13% -$4.07M 0.01% 1115
2017
Q1 		$30.9M Sell
26,253
-9,878
-27% -$10.1M 0.01% 1124
2016
Q4 		$28.9M Buy
36,131
+3,272
+10% +$2.6M 0.01% 1129
2016
Q3 		$28.9M Sell
32,859
-1,173
-3% -$850K 0.01% 1071
2016
Q2 		$19.1M Sell
34,032
-730
-2% -$413K 0.01% 1351
2016
Q1 		$19.1M Sell
34,762
-1,895
-5% -$1.16M 0.01% 1307
2015
Q4 		$30.5M Buy
36,657
+12,761
+53% +$12.7M 0.01% 1050
2015
Q3 		$26.5M Buy
23,896
+3,586
+18% +$6.54M 0.01% 1110
2015
Q2 		$42.9M Sell
20,310
-8,015
-28% -$16.3M 0.02% 894
2015
Q1 		$44.3M Sell
28,325
-480
-2% -$633K 0.02% 867
2014
Q4 		$34.2M Buy
28,805
+28,492
+9,103% +$19M 0.01% 957
2014
Q3 		$146K Sell
313
-104
-25% -$48K ﹤0.01% 4492
2014
Q2 		$209K Buy
417
+5
+1% +$1.6K ﹤0.01% 4352
2014
Q1 		$121K Sell
412
-16
-4% -$4.85K ﹤0.01% 4566
2013
Q4 		$116K Buy
428
+366
+590% +$102K ﹤0.01% 4482
2013
Q3 		$22K Buy
+62
New +$23K ﹤0.01% 4922

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's BLUE Position: Q2 2025 in Review

Wells Fargo sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 6,499 shares — an estimated $31.7K sold.

Wells Fargo first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $44.3M in Q1 2015. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Wells Fargo reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Wells Fargo sold 6,499 bluebird bio shares in Q2 2025, an estimated $31.7K.
  • Wells Fargo first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
  • Wells Fargo's bluebird bio position peaked at $44.3M in Q1 2015.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.